Cite
HARVARD Citation
Kiyomiya, M. et al. (2023). Lymph-node metastasis from gastric adenocarcinoma in a patient bearing a germ line missense variant MSH2 c.1808A > T (Asp603Val) responds to the immune checkpoint inhibitor pembrolizumab. Japanese journal of clinical oncology. pp. 270-274. [Online].